Inventors:
Mamatha Shekar - Cupertino CA, US
Zhaomei Zhang - Sunnyvale CA, US
Mitchell Caldwell - Menlo Park CA, US
Zuxiong Chen - Mountain View CA, US
Zhenbin Fan - Mountain View CA, US
John McNeal - Oakland CA, US
Rosalie Nolley - Menlo Park CA, US
Thomas Stamey - Portola Valley CA, US
Janet Warrington - Los Altos CA, US
John Palma - San Ramon CA, US
Assignee:
Affymetrix, INC. - Santa Clara CA
International Classification:
C12Q001/68
Abstract:
Many genes are affected in prostate cancers which have not been previously identified. This includes genes that have been up-regulated or down-regulated. Monitoring the expression levels of these genes is useful to identify the existence of prostate cancer. Also, monitoring the expression levels of these genes is useful to predict the effectiveness of treatment, outcome, use of therapeutics, and screening drugs useful for the treatment of prostate cancer.